Skip to main content
Premium Trial:

Request an Annual Quote

Dirk van den Boom

Sequenom has appointed Dirk van den Boom as president and CEO. He will retain his seat on the company's board of directors. In September, van den Boom was appointed interim president and CEO. Before that, he served as chief scientific and strategy officer. He joined Sequenom in 1998 and has held various management roles within the research and development department.

The Scan

Fertility Fraud Found

Consumer genetic testing has uncovered cases of fertility fraud that are leading to lawsuits, according to USA Today.

Ties Between Vigorous Exercise, ALS in Genetically At-Risk People

Regular strenuous exercise could contribute to motor neuron disease development among those already at genetic risk, Sky News reports.

Test Warning

The Guardian writes that the US regulators have warned against using a rapid COVID-19 test that is a key part of mass testing in the UK.

Science Papers Examine Feedback Mechanism Affecting Xist, Continuous Health Monitoring for Precision Medicine

In Science this week: analysis of cis confinement of the X-inactive specific transcript, and more.